Document Detail


Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances.
MedLine Citation:
PMID:  19426416     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Often, too little consideration is given to the fluids used in all forms of continuous renal replacement therapy (CRRT). However, errors in fluid prescription, delivery, or creation can be rapidly fatal; in addition, fluid associated expenses can be the overriding cost in continuous renal replacement therapies. While a standard solution is frequently acceptable in most clinical circumstances, specific electrolyte and acid-base disturbances may direct changes in fluid delivery and composition. Decisions regarding fluids, whether dialysate versus replacement, including generation and composition of therapy are discussed in this review.
Authors:
Michael A Kraus
Related Documents :
5500736 - Intracellular hydrolysis of short chain glycerides by rat small intestine in vitro and ...
7170676 - Metabolic comfort and motivation of preference for ethanol.
6627956 - Amino acids and thiobarbituric acid reactive substances in cerebrospinal fluid and plas...
1548476 - Decrease of extracellular taurine in the rat dorsal hippocampus after central nervous a...
22123636 - Periconceptional folic acid-containing multivitamin supplementation for the prevention ...
14735446 - Cytotoxic triterpenoids from the fruits of zizyphus jujuba.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in dialysis     Volume:  22     ISSN:  1525-139X     ISO Abbreviation:  Semin Dial     Publication Date:    2009 Mar-Apr
Date Detail:
Created Date:  2009-05-11     Completed Date:  2009-08-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8911629     Medline TA:  Semin Dial     Country:  United States    
Other Details:
Languages:  eng     Pagination:  137-40     Citation Subset:  IM    
Affiliation:
Department of Medicine, Division of Nephrology, Indiana University Medical School and Clarian Health, Indianapolis, IN 46202, USA. mkraus@iupui.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acid-Base Imbalance / etiology,  prevention & control*
Dialysis Solutions / chemistry*,  therapeutic use
Electrolytes / analysis*,  therapeutic use
Humans
Kidney Failure / therapy
Magnesium / analysis
Phosphorus / analysis
Potassium / analysis
Renal Replacement Therapy / adverse effects,  methods*
Sodium / analysis
Water-Electrolyte Imbalance / etiology,  prevention & control*
Chemical
Reg. No./Substance:
0/Dialysis Solutions; 0/Electrolytes; 7439-95-4/Magnesium; 7440-09-7/Potassium; 7440-23-5/Sodium; 7723-14-0/Phosphorus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vascular access for continuous renal replacement therapy.
Next Document:  Anticoagulation for continuous renal replacement therapy.